Mounjaro 2.5 mg/dose KwikPen solution for injection in pre-filled pen

DRUG4 trials

Sponsors

Psykiatrisk Center Kobenhavn, F. Hoffmann-La Roche AG, University College Dublin, Klinikum der Technischen Universitaet Muenchen (TUM Klinikum)

Conditions

Endometrial adenocarcinomaObesitySchizophrenia and Alcohol Use Disorder

Phase 2

Effect of tirzepatide on alcohol intake and reward processing in patients diagnosed with schizophrenia and alcohol use disorder

RecruitingCTIS2024-518608-28-00

Psykiatrisk Center KobenhavnSchizophrenia and Alcohol Use Disorder

Start: 2025-05-01Target: 108Updated: 2026-01-07

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Assess Efficacy, Safety, and Tolerability of RO7204239 in Combination with Tirzepatide in Participants with Obesity or Overweight with at least One Weight-Related Comorbidity

Active, not recruitingCTIS2024-519561-22-00

F. Hoffmann-La Roche AGObesity

Start: 2025-07-07Target: 78Updated: 2025-09-26

TREAT-EC (Tirzepatide in the treatment of endometrial cancer) - a clinical trial

Not yet recruitingCTIS2025-523877-40-00

University College DublinEndometrial adenocarcinoma

Target: 78Updated: 2026-04-02

Phase 4

A Phase IV, Randomized Controlled Trial to Evaluate the Effects of Resistance Training Versus Usual Care on Thigh Muscle Volume During Treatment with the Dual GIP/GLP-1 Receptor Agonist Tirzepatide in Adults with Obesity

Not yet recruitingCTIS2026-526200-69-00

Klinikum der Technischen Universitaet Muenchen (TUM Klinikum)Obesity

Target: 150Updated: 2026-08-04